Department of Defense Funding |
Project # |
Title |
Status |
FY'94 |
FY'95 |
FY'96 |
FY'97 |
FY'98 |
94-98 Total |
Projected FY'99 |
DoD-00 |
1999 DoD Program Element Initiative |
Pending |
|
|
|
|
|
$0 |
$19,000,000 |
DoD-1 |
Epidemiologic Studies of Morbidity Among Gulf War Veterans: A Search for Etiologic Agents and Risk Factors |
Ongoing |
$725,000 |
$1,010,000 |
$2,250,000 |
$2,000,000 |
$2,654,000 |
$8,639,000 |
$1,500,000 |
DoD-1A |
A Study of Symptoms Among 1500 Seabees |
Complete |
|
|
|
|
|
$0 |
|
DoD-1B |
A Comparative Study of Hospitalizations among Active Duty Personnel who Participated in the Gulf War and Similar Personnel who did not |
Complete |
|
|
|
|
|
$0 |
|
DoD-1C |
A comparative study of pregnancy outcomes among gulf war veterans and other active-duty personnel |
Complete |
|
|
|
|
|
$0 |
|
DoD-1D |
Adverse Reproductive Outcomes in Gulf War veterans |
Ongoing |
|
|
|
|
|
$0 |
|
DoD-1E |
Seabee Health Study |
Ongoing |
|
|
|
|
|
$0 |
|
DoD-1F |
A Comparison of Nonfederal Hospitalization Experience Among Veterans in California who have separated from active service |
Complete |
|
|
|
|
|
$0 |
|
DoD-1G |
Prevalence of Congenital Anomalies Among Children of Persian Gulf War Veterans. |
Ongoing |
|
|
|
|
|
$0 |
|
DoD-2 |
Physiological and Neurobehavioral Effects in Rodents from Exposure to Pyridostigmine, Fuels, and DEET (short title: Toxicity of Simulated PGW Exposure) |
Complete |
$90,000 |
$0 |
$0 |
$0 |
|
$90,000 |
|
DoD-4 |
The General Well-Being of Gulf War Era Service Personnel from the States of Pennsylvania and Hawaii: A Survey |
Complete |
$0 |
|
|
|
|
$0 |
|
DoD-7A |
Health Risk Assessment of Embedded Depleted Uranium: Behavior, Physiology, Histology, and Biokinetic Modeling |
Complete |
$897,000 |
$0 |
$0 |
$0 |
$0 |
$897,000 |
|
DoD-7B |
Carcinogenicity of Depleted Uranium Fragments |
Ongoing |
$897,814 |
$0 |
$0 |
$0 |
$0 |
$897,814 |
$0 |
DoD-8 |
Research on Diagnostic Tools for Leishmaniasis |
Ongoing |
$773,000 |
$895,000 |
$652,000 |
$695,000 |
$694,000 |
$3,709,000 |
$0 |
DoD-8A |
Serologic Diagnosis of Viscerotropic Leishmaniasis (VTL) |
Complete |
|
|
|
|
|
$0 |
|
DoD-8B |
Development of a Leishmania Skin Test Antigen (LSTA) |
Ongoing |
|
|
|
|
|
$0 |
|
DoD-9 |
Identification of the Genetic Factors Which Control Tropism in Leishmania |
Complete |
$0 |
$150,000 |
$0 |
$0 |
$0 |
$150,000 |
|
DoD-10 |
Pyridostigmine Synergistic Toxicity |
Complete |
$42,000 |
$44,000 |
|
|
|
$86,000 |
|
DoD-11 |
Male/Female Differential Tolerances to Pyridostigmine Bromide |
Complete |
$549,000 |
$359,000 |
$0 |
$0 |
|
$908,000 |
|
DoD-12 |
Forward Deployable Diagnostics for Infectious Diseases |
Ongoing |
$520,000 |
$1,162,000 |
$439,000 |
$932,000 |
$803,000 |
$3,856,000 |
$0 |
DoD-13 |
Effects of Persian Gulf War Service on Military Working Dogs |
Ongoing |
$0 |
$0 |
$97,000 |
$200,000 |
$120,000 |
$417,000 |
$200,000 |
DoD-14 |
Risk Factors Among US Army Soldiers for Enrolling on the Department of Veterans Affairs Gulf War |
Complete |
$120,000 |
$0 |
$0 |
$0 |
|
$120,000 |
|
DoD-15 |
Comparative Mortality Among US Military Personnel Worldwide During Operations Desert Shield and Desert Storm |
Complete |
$20,000 |
$0 |
|
|
|
$20,000 |
|
DoD-16 |
Kuwait Oil Fire Health Risk Assessment |
Complete |
$345,000 |
$137,000 |
$50,000 |
$127,000 |
|
$659,000 |
|
DoD-17 |
Retrospective Studies Involving Military Use of Pyridostigmine as a Pretreatment for Nerve Agent Poisoning |
Complete |
$21,000 |
|
|
|
|
$21,000 |
|
DoD-18 |
Kuwait Oil Fires Troop Exposure Assessment Model (TEAM) |
Ongoing |
$68,000 |
$151,000 |
$770,000 |
$193,000 |
$290,000 |
$1,472,000 |
$295,000 |
DoD-19 |
Persian Gulf Veterans Health Tracking System |
Ongoing |
|
$25,000 |
$0 |
$0 |
$450,000 |
$475,000 |
$450,000 |
DoD-20 |
A Statistical Study Correlating Illnesses in Gulf War Veterans to Battlefield Locations of Afflicted US Army Personnel During the Iraq-Kuwait War; Part 1: Method to Relate Troop Deployment and Illnesses in GWVs |
Complete |
$50,000 |
$0 |
|
|
|
$50,000 |
|
DoD-21 |
Study of Variability In Pyridostigmine Inhibition of Blood Cholinesterases in Healthy Adults and Individuals With Symptoms Following Participation in Operation Desert Storm |
Complete |
$38,000 |
$100,000 |
$0 |
$0 |
|
$138,000 |
|
DoD-22 |
Chronic Organophosphorus Exposure and Cognition |
Complete |
$375,000 |
$0 |
$0 |
$0 |
$0 |
$375,000 |
|
DoD-23 |
Acute and Long-Term Impact of Deployment to Southwest Asia on the Physical and Mental Health of Soldiers and their Families |
Complete |
$621,000 |
$688,000 |
$764,000 |
$985,000 |
|
$3,058,000 |
|
DoD-30 |
Epidemiological Studies Persian Gulf War Illnesses, PG Women's Health Linkage Study |
Ongoing |
|
$779,000 |
$0 |
$0 |
$0 |
$779,000 |
$0 |
DoD-31 |
Dysregulation of the Stress Response in the Persian Gulf Syndrome |
Ongoing |
|
$971,000 |
$0 |
$0 |
$0 |
$971,000 |
$0 |
DoD-32 |
Neuropsychological Functioning in Persian Gulf Era Veterans |
Ongoing |
|
$353,000 |
$0 |
$0 |
$0 |
$353,000 |
$0 |
DoD-33 |
Effects of Pyridostigmine in Flinders Line Rats Differing in Cholinergic |
Ongoing |
|
$354,000 |
$0 |
$0 |
$0 |
$354,000 |
$0 |
DoD-34 |
Characterization of Emissions from Heaters Burning Leaded Diesel Fuel in Unvented Tents |
Ongoing |
|
$283,000 |
$0 |
$0 |
$0 |
$283,000 |
$0 |
DoD-35 |
Feasibility of Investigating Whether There is a Relationship Between Birth Defects and Service in the Gulf War |
Ongoing |
|
$427,000 |
$10,000 |
$63,000 |
$0 |
$500,000 |
$0 |
DoD-36 |
Fatigue in Persian Gulf Syndrome-Physiologic Mechanisms |
Ongoing |
|
$416,000 |
$138,000 |
$0 |
$0 |
$554,000 |
$0 |
DoD-37 |
Neurobehavioral and Immunological Toxicity of Pyridostigmine, Permethrin, and DEET in Male and Female Rats |
Ongoing |
|
$934,000 |
$5,000 |
$0 |
$0 |
$939,000 |
$0 |
DoD-38 |
Diagnostic Antigens of Leishmania tropica |
Complete |
|
$612,000 |
$0 |
$0 |
$0 |
$612,000 |
|
DoD-39 |
A Controlled Epidemiological and Clinical Study into the Effect of Gulf War Service on Servicemen and Women of the United Kingdom Armed |
Ongoing |
|
$865,000 |
$0 |
$28,400 |
$155,000 |
$1,048,400 |
$0 |
DoD-40 |
Psychological and Neurobiological Consequences of the Gulf War Experience |
Ongoing |
|
$264,000 |
$0 |
$0 |
$0 |
$264,000 |
$0 |
DoD-41 |
Evaluation of Muscle Function in Persian Gulf veterans |
Ongoing |
|
$906,000 |
$0 |
$0 |
$0 |
$906,000 |
$0 |
DoD-42 |
The Symptomatic Persian Gulf Veterans Protocol: An Analysis of Risk Factors with an Immunologic and Neuropsychiatric Assessment |
Ongoing |
|
|
$700,000 |
$0 |
$0 |
$700,000 |
$0 |
DoD-44 |
Investigation of Seminal Plasma Hypersensitivity Reactions |
Ongoing |
|
|
$634,000 |
$0 |
$0 |
$634,000 |
$0 |
DoD-45 |
Physical and Emotional Health of Gulf War Veterans Women |
Ongoing |
|
|
$100,000 |
$100,000 |
$0 |
$200,000 |
$0 |
DoD-46 |
Exploratory Data Analysis with the CCEP |
Complete |
|
|
$60,000 |
$100,000 |
|
$160,000 |
|
DoD-47 |
Study of Mycoplasmal Infections in Gulf War Veterans |
Complete |
|
|
$112,000 |
$0 |
$0 |
$112,000 |
|
DoD-48 |
Assessment of Genomic Instability via Chromosome 7 Inversion Frequency in a Symptomatic Cohort of Gulf War Veterans vs Selected Control Groups |
Complete |
|
|
$74,000 |
$0 |
|
$74,000 |
|
DoD-49 |
Diagnosis and Dosemitry of Exposure to Sulfur Mustard: Development of Standard Operating Procedures and Exploratory Research on Protein Adducts |
Ongoing |
|
|
$927,000 |
$0 |
$0 |
$927,000 |
$0 |
DoD-50 |
Toxicokinetics of 0-Ethyl S-(2-Diisopropylaminoethyl) Methylphosphonothioate [(+)-VX] in Rats, Hairless Guinea Pigs and Marmosets - Identification of Metabolic Pathways |
Ongoing |
|
|
$699,000 |
$0 |
$0 |
$699,000 |
$0 |
DoD-51 |
Transgenic Engineering of Cholinesterases: Tools for Exploring Cholinergic Responses |
Ongoing |
|
|
$864,000 |
$0 |
$0 |
$864,000 |
$0 |
DoD-52 |
Female Gender and Other Potential Predictors of Functional Health Status Among Persian Gulf War veterans |
Ongoing |
$414,000 |
$0 |
$0 |
$0 |
$0 |
$414,000 |
$0 |
DoD-53 |
Long-Term Effects of Subclinical Exposures to Sarin |
Ongoing |
|
|
$1,000,000 |
$400,000 |
$0 |
$1,400,000 |
$0 |
DoD-54 |
Assessment of Subchronic Neurobehavioral and Neuropathologic Effects in Rats |
Ongoing |
|
|
$315,000 |
$100,000 |
$0 |
$415,000 |
$0 |
DoD-55 |
Low-Level Exposure to GB Vapor in Air: Diagnosis/Dosimetry, Lowest Observable Effect Levels, Performance-Incapacitation, and Possible |
Ongoing |
|
|
$500,000 |
$136,000 |
$0 |
$636,000 |
$0 |
DoD-56 |
Low-Level Sarin Neurotoxicity and Its Modulation by Pyridostigmine |
Ongoing |
|
|
$685,000 |
$100,000 |
$0 |
$785,000 |
$0 |
DoD-57 |
Physiologic Effects of Stress in Gulf War Veterans |
Ongoing |
|
|
|
$909,000 |
$0 |
$909,000 |
$0 |
DoD-58 |
Illness Among Persian Gulf War Veterans: Case Validation Studies |
Ongoing |
|
|
|
$2,208,000 |
$0 |
$2,208,000 |
$0 |
DoD-59 |
Pyridostigmine-induced Neurodegeneration: Role of neuronal Apoptosis |
Ongoing |
|
|
|
$625,000 |
$0 |
$625,000 |
$0 |
DoD-60 |
Butyrylcholinesterase Genetic Variants in Persons with Gulf War Illness |
Ongoing |
|
|
|
$125,000 |
$0 |
$125,000 |
$0 |
DoD-61 |
Neurophysiologic and Neuropathologic Effects in Monkeys of Low Level Exposures to Sarin, Pyridostigmine, Pesticides, and Botulinum Toxoid |
Ongoing |
|
|
|
$1,586,000 |
$0 |
$1,586,000 |
$0 |
DoD-62 |
Sarin and Pyridostigmine Interaction under Physical Stress: Neurotoxic Effects in |
Ongoing |
|
|
|
$201,000 |
$0 |
$201,000 |
$0 |
DoD-63 |
PGW Veterans: Epidemiological and Clinical Evidence for Residual Organophosphate Neurotoxicity |
Ongoing |
|
|
|
$1,626,000 |
$0 |
$1,626,000 |
$0 |
DoD-64 |
Individual Differences in Neurobehavioral Effects of Pyridostigmine |
Ongoing |
|
|
|
$1,900,000 |
$18,516 |
$1,918,516 |
$0 |
DoD-65 |
Multi-Disciplinary Pathophysiologic Studies of Neurotoxic Gulf War-Related Neurologic Syndromes |
Pending |
|
|
|
$3,000,000 |
$0 |
$3,000,000 |
$0 |
DoD-66 |
Testing for Mycoplasma Infection: Criterion Validity and Replicability of Nucleoprotein Gene Tracking and Forensic Polymerase Chain Reaction Tests |
Ongoing |
|
|
$49,940 |
$100,000 |
$63,825 |
$213,765 |
$100,000 |
DoD-67 |
Antibacterial Treatment Method Based Upon the Excretion of Dead and Decaying Spherical Bacteria |
Ongoing |
|
|
$0 |
$3,400,000 |
$0 |
$3,400,000 |
$0 |
DoD-69 |
Five Year Follow-Up of Army Personnel Potentially Exposed to Chemical Warfare |
Ongoing |
|
|
|
$946,160 |
$0 |
$946,160 |
$0 |
DoD-70 |
War Syndromes from 1900 to the Present: Symptom Patterns and Long Term Health Outcomes |
Ongoing |
|
|
|
$734,687 |
$0 |
$734,687 |
$115,000 |
DoD-71 |
A Comparison of Post-Deployment Hospitalization Incidence between Vietnam and Gulf War Veterans |
Ongoing |
$0 |
$0 |
$0 |
$566,000 |
$0 |
$566,000 |
$0 |
DoD-72 |
Long-Term Effects of Subchronic Exposure to Sarin, Alone and with Stress and Other Chemicals |
Ongoing |
|
|
|
$996,000 |
$0 |
$996,000 |
|
DoD-73 |
Post-Deployment Morbid Stress, Behavior and Health: Developing a Model for Predicting Morbidity, Mortality, and other Adverse Outcomes |
Ongoing |
|
|
|
$500,000 |
$0 |
$500,000 |
$0 |
DoD-74 |
Relationship of Stress Exposures to Health in GWVs |
Ongoing |
|
|
|
$161,489 |
$1,991,330 |
$2,152,819 |
$0 |
DoD-75 |
Toxic Interactions of Prophylactic Drugs and Pesticides |
Ongoing |
|
|
|
|
$1,380,157 |
$1,380,157 |
$0 |
DoD-76 |
Evaluation of Immunotoxicity Due to Concurrent Exposure to DEET, Pyridostigmine, and JP-8 Jet Fuel |
Ongoing |
|
|
|
|
$448,369 |
$448,369 |
$0 |
DoD-77 |
Percutaneous Absorption of Chemical Mixtures Relevant to the Gulf War |
Ongoing |
|
|
|
|
$760,031 |
$760,031 |
$0 |
DoD-78 |
Experimental Models of Gulf War Syndrome |
Ongoing |
|
|
|
|
$2,179,097 |
$2,179,097 |
$0 |
DoD-79 |
Military Operational Stress-Related Illnesses: Time-course of Stress-Induced Impairment of the |
Ongoing |
|
|
|
$100,200 |
$0 |
$100,200 |
$0 |
DoD-80 |
Molecular Regulation of Corticosteroid Receptor Expression in Stress-Responsive Cells |
Ongoing |
|
|
|
$297,400 |
$0 |
$297,400 |
$0 |
DoD-81 |
Immunotoxicity Due to Coexposure of DEET, PB, and Stress |
Ongoing |
|
|
|
$300,000 |
$0 |
$300,000 |
$0 |
DoD-82 |
Feasibility of Developing a Registry of PTSD-Affected Sibling |
Ongoing |
|
|
|
$172,000 |
$0 |
$172,000 |
|
DoD-83 |
Risk for Stress-Related Substance Abuse: Effects of Family History of Alcoholism |
Ongoing |
|
|
|
$299,700 |
$0 |
$299,700 |
$0 |
DoD-84 |
Psychobiological Alterations Of Persian Gulf War Veterans with and without PTSD |
Ongoing |
|
|
|
$300,000 |
$0 |
$300,000 |
$0 |
DoD-85 |
Central Nervous System Cytokines and CRH in Gulf War Veterans with Multiple Unexplained Symptoms |
Ongoing |
|
|
|
$149,900 |
$149,200 |
$299,100 |
$0 |
DoD-86 |
Effects of Combat Stress on the Structure and Function of the Hippocampus |
Ongoing |
|
|
|
$300,000 |
$297,800 |
$597,800 |
$0 |
DoD-87 |
Measurement and Validation of Psychosocial Risk and Resilience Factors |
Ongoing |
|
|
|
$289,100 |
$0 |
$289,100 |
$0 |
DoD-88 |
Clinical Relevance of Novel Immunological Markers in PTSD |
Ongoing |
|
|
|
$242,300 |
$0 |
$242,300 |
$0 |
DoD-89 |
Limbic Blood Flow and Opiate Receptor and MR Imaging in PTSD |
Ongoing |
|
|
|
$288,500 |
$0 |
$288,500 |
$0 |
DoD-90 |
SPECT Benzodiazepine Receptor and MR Imaging in PTSD |
Ongoing |
|
|
|
$200,000 |
$100,000 |
$300,000 |
$0 |
DoD-91 |
Neurological and Circadian Substrates of PTSD-Like Behaviors |
Ongoing |
|
|
|
$300,000 |
$299,000 |
$599,000 |
$0 |
DoD-92 |
Traumatic Experiences Enhance Cue-Dependent Learning |
Ongoing |
|
|
|
$249,700 |
$0 |
$249,700 |
$0 |
DoD-93 |
Follow-Up Investigation of Troops Exposed to Nerve Agents at Aberdeen Proving |
Pending |
|
|
|
|
|
$0 |
$933,000 |
|
DoD Total Funds |
|
$6,565,814 |
$11,885,000 |
$11,894,940 |
$29,232,536 |
$12,853,325 |
$72,853,325 |
$22,593,000 |
Department of Health and Human Services Funding
|
Project # |
Title |
Status |
FY'94 |
FY'95 |
FY'96 |
FY'97 |
FY'98 |
94-98 Total |
Projected
FY'99 |
HHS-1 |
Health Assessment of Persian Gulf War Veterans from Iowa |
Ongoing |
|
$1,764,782 |
$1,616,755 |
$0 |
$0 |
$3,381,537 |
$162,000 |
HHS-2 |
Disease Cluster in a Pennsylvania Air National Guard Unit, EPI-AID 95-18 |
Ongoing |
|
$750,000 |
$0 |
$0 |
$16,055 |
$766,055 |
$0 |
HHS-3 |
Biomarkers of Susceptibility and Polycyclic Aromatic Hydrocarbon (PAH) Exposure in Urine and blood Cell DNA from U.S. Army Soldiers Exposed to Kuwaiti Oil |
Complete |
$0 |
$0 |
$0 |
$0 |
|
$0 |
|
HHS-4 |
Suspected Increase of Birth Defects and health Problems Among Children Born to Persian Gulf War Veterans In Mississippi |
Complete |
$0 |
$0 |
|
|
|
$0 |
|
HHS-5 |
Cognitive Function and Symptom Patterns in Gulf War Veterans |
Ongoing |
|
|
|
|
$600,000 |
$600,000 |
$558,000 |
HHS-6 |
Defining Gulf War Illness |
Ongoing |
|
|
|
|
$600,000 |
$600,000 |
$480,000 |
HHS-7 |
Immunotoxicity of Dermal Permethrinand Cis-Urcanic Acid |
Ongoing |
|
|
|
|
$175,706 |
$175,706 |
$192,445 |
HHS-8 |
Strategy to Identify Non-Additive Response to Chemical Mixtures |
Ongoing |
|
|
|
|
$242,586 |
$242,586 |
$247,933 |
|
HHS Total Funds |
|
$0 |
$2,514,782 |
$1,616,755 |
$0 |
$1,634,347 |
$5,765,884 |
$1,640,378 |
Department of Veterans Affairs Funding
|
Project # |
Title |
Status |
FY'94 |
FY'95 |
FY'96 |
FY'97 |
FY'98 |
94-98 Total |
Projected FY'99 |
VA-1 |
VA Mortality Study and VA National Health Survey of Persian Gulf Veterans (combined for FY'94-97); VA Mortality Study (FY' 98 -present) |
Ongoing |
$546,000 |
$340,000 |
$1,980,000 |
$440,032 |
$178,197 |
$3,484,229 |
$166,848 |
VA-2 |
VA National Survey of Persian Gulf Veterans |
Ongoing |
|
|
|
|
|
$0 |
|
VA-2A |
VA National Survey of Persian Gulf Veterans - Phase I |
Complete |
|
|
|
|
$18,111 |
$18,111 |
|
VA-2B |
VA National Survey of Persian Gulf Veterans - Phase II |
Ongoing |
|
|
|
|
$271,551 |
$271,551 |
$0 |
VA-2C |
VA National Survey of Persian Gulf Veterans - Phase III |
Ongoing |
|
|
|
|
$1,601,280 |
$1,601,280 |
$2,340,774 |
VA-3 |
Use of Roster of Veterans Who Served in Persian Gulf Area |
Complete |
|
|
|
|
$0 |
|
|
VA-4 |
Boston Environmental Hazards Research |
Ongoing |
$98,300 |
$500,000 |
$500,000 |
$500,000 |
$500,000 |
$2,098,300 |
$500,000 |
VA-4A |
Evaluation of Cognitive Functioning of PGWVs |
Ongoing |
|
|
|
|
|
$0 |
|
VA-4B |
Evaluation of Neurological Functioning in Persian Gulf Veterans (see new HHS-5) |
Complete |
|
|
|
|
|
$0 |
|
VA-4C |
Gulf War And Vietnam Veterans Cancer Incidence Surveillance |
Ongoing |
|
|
|
|
|
$0 |
|
VA-4COR |
Boston Environmental Hazards Research Center - Core |
Ongoing |
|
|
|
|
|
$0 |
|
VA-4D |
Evaluation of Respiratory Dysfunction Among Gulf War |
Ongoing |
|
|
|
|
|
$0 |
|
VA-4E |
The Aromatic Hydrocarbon Receptor (AhR) as a Biomarker of Susceptibility |
Ongoing |
|
|
|
|
|
$0 |
|
VA-4F |
Validity of Computerized Tests |
Ongoing |
|
|
|
|
|
$0 |
|
VA-5 |
East Orange Environmental Hazards Research Center |
Ongoing |
$100,000 |
$500,000 |
$500,000 |
$500,000 |
$500,000 |
$2,100,000 |
$500,000 |
VA-5A |
Health and Exposure Survey of Persian Gulf Veterans |
Ongoing |
|
|
|
|
|
$0 |
|
VA-5B |
Physiological and Psychological Assessments of Persian Gulf Veterans |
Complete |
|
|
|
|
|
$0 |
|
VA-5C |
Effects of Exertion and Chemical Stress on Persian Gulf Veterans |
Ongoing |
|
|
|
|
|
$0 |
|
VA-5COR |
East Orange Environmental Hazards Research Center - Core |
Ongoing |
|
|
|
|
|
$0 |
|
VA-5D |
Effects of Genetics and Stress on Responses to Environmental Toxins |
Complete |
|
|
|
|
|
$0 |
|
VA-6 |
Portland Environmental Hazards Research Center: Environment, Veterans Health and the Gulf War Syndrome |
Ongoing |
$99,279 |
$499,583 |
$498,695 |
$499,198 |
$499,926 |
$2,096,681 |
$500,000 |
VA-6A |
Psychosocial, Neuropsychological and Neurobehavioral Assessment (Project I) |
Ongoing |
|
|
|
|
|
$0 |
|
VA-6B |
Clinical and Neuroendocrine Aspects of Fibromyalgia (Project II) |
Ongoing |
|
|
|
|
|
$0 |
|
VA-6C |
Neurotoxicity of Environmental Pollutants and Warfare Agents (Project III) |
Ongoing |
|
|
|
|
|
$0 |
|
VA-6COR |
Core: Portland Environmental Hazards Research Center: Environment, Veterans Health and the Gulf War Syndrome. Core Project for Clinical and Epidemiology Research |
Ongoing |
|
|
|
|
|
$0 |
|
VA-6D |
DNA Damage from Chemical Agents and Its Repair (Project IV) |
Ongoing |
|
|
|
|
|
$0 |
|
VA-6E |
Clinical and Epidemiology Leishmania Research |
Ongoing |
|
|
|
|
|
$0 |
|
VA-7 |
Desert Storm Reunion Survey |
Complete |
$0 |
$50,000 |
|
|
|
$50,000 |
|
VA-8 |
Psychological Test Data of Gulf War Veterans Over Time |
Ongoing |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
VA-9 |
Evaluation of Cognitive Functioning in Persian Gulf War Veterans Reporting War-related Health Problems |
Complete |
$0 |
$0 |
$20,000 |
|
|
$20,000 |
|
VA-10 |
Memory and Attention in PTSD |
Ongoing |
$0 |
$0 |
$63,700 |
$57,000 |
$57,600 |
$178,300 |
$0 |
VA-11 |
Neuropsychological Functioning in Veterans |
Complete |
$0 |
$0 |
|
|
|
$0 |
|
VA-12 |
Psychological Assessment of Operation Desert Storm |
Complete |
$0 |
$0 |
$0 |
$0 |
|
$0 |
|
VA-13 |
Neurobehavioral Aspects of Persian Gulf Experiences: A Pilot Study |
Complete |
$0 |
$50,000 |
|
|
|
$50,000 |
|
VA-15 |
Vaccine-Mediated Immunity Against Leishmaniasis |
Ongoing |
$64,300 |
$64,300 |
$0 |
$82,600 |
$80,000 |
$291,200 |
$79,400 |
VA-16 |
Protective Immunity in Experimental Visceral Leishmaniasis |
Complete |
|
$60,200 |
$60,700 |
$54,900 |
|
$175,800 |
|
VA-17 |
Immunological Evaluation of Persian |
Complete |
$0 |
$0 |
|
|
|
$0 |
|
VA-18 |
Chronic Gastrointestinal Illness in Persian Gulf Veterans |
Complete |
|
$0 |
$0 |
|
|
$0 |
|
VA-20 |
Psychological Adjustment in Operation Desert Shield/Storm |
Complete |
|
|
|
|
|
$0 |
|
VA-21 |
A Comparison of PTSD Symptomatology among Three Army Medical Units Involved in ODS |
Complete |
$0 |
$0 |
|
|
|
$0 |
|
VA-36 |
Stress Symptoms and Their Causal Attribution in Desert Storm Veterans |
Complete |
|
$0 |
$0 |
$0 |
|
$0 |
|
VA-40 |
Musculoskeletal Symptoms in Gulf War Syndrome |
Ongoing |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
VA-46 |
Diarrhea in Persian Gulf Veterans: An Irritable Bowel-Like Disorder |
Ongoing |
|
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
VA-47 |
Retrospective Verification of Mustard |
Ongoing |
|
|
|
$37,300 |
$37,300 |
$74,600 |
$37,300 |
VA-48 |
Cross-Sensitization as a CNS Model for Gulf War Chemical Intolerance |
Ongoing |
|
|
|
|
$99,900 |
$99,900 |
$98,800 |
VA-49 |
Sensitivity to Pyridostigmine Bromide: Persistent Neural Dysfunction |
Ongoing |
|
|
|
|
$184,400 |
$184,400 |
$13,300 |
VA-50 |
Neuropsychological Function in Gulf War Veterans |
Complete |
|
$0 |
$0 |
$0 |
|
$0 |
|
VA-51 |
Psychobiological Assessment of Desert Storm Veterans |
Ongoing |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
$0 |
VA-53 |
Spouses and Children Program |
Ongoing |
|
|
|
$101,360 |
$98,651 |
$200,011 |
$1,799,989 |
VA-54 |
Follow-up of Psychological and Neurocognitive Gulf War Outcomes: Relation to Stress |
Ongoing |
|
|
|
|
|
$0 |
$102,000 |
VA-55 |
Antibiotic Treatment of Gulf War Veterans' Illnesses |
Ongoing |
|
|
|
|
$50,000 |
$50,000 |
$2,000,000 |
|
VA Total Funds |
|
$907,879 |
$2,064,083 |
$3,623,095 |
$2,272,390 |
$4,176,916 |
$13,044,363 |
$8,138,411 |
VA/DoD Programs Funding
|
Project # |
Title |
Status |
FY'94 |
FY'95 |
FY'96 |
FY'97 |
FY'98 |
94-98 Total |
Projects FY'99 |
VA/DoD-1D |
VA Cooperative Study 470: A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans with Gulf War Illnesses (GWIs) |
|
|
|
|
|
$4,500,000 |
$4,500,000 |
|
VA/DoD-1V |
VA Cooperative Study 470: A Randomized, Multi-Center, Controlled Trial of Multi-Modal Therapy in Veterans with GWIs |
Ongoing |
|
|
|
|
$50,000 |
$50,000 |
$2,500,000 |
VA/DoD-2D |
VA/DoD Core Funding of the Medical Follow-Up Agency |
Ongoing |
$250,000 |
$250,000 |
$250,000 |
$250,000 |
$250,000 |
$1,250,000 |
$250,000 |
VA/DoD-2DA |
Follow-Up Investigation of Troops Exposed to Nerve Agents at Aberdeen Proving Ground (Pilot Study) |
|
|
|
|
|
|
$0 |
|
VA/DoD-2DB |
Patterns of Pre-Persian Gulf War Illness and Health Care Seeking - Pilot Study |
|
|
|
|
|
|
$0 |
|
VA/DoD-2V |
VA/DoD Core Funding of the Medical Follow-Up Agency |
Ongoing |
$250,000 |
$250,000 |
$250,000 |
$250,000 |
$250,000 |
$1,250,000 |
$250,000 |
VA/DoD-2VA |
Follow-Up Investigation of Troops Exposed to Nerve Agents at Aberdeen Proving Ground (Pilot Study) |
Complete |
|
|
|
|
|
$0 |
|
VA/DoD-2VB |
Patterns of Pre-Persian Gulf War Illness and Health Care Seeking-Pilot Study |
Complete |
|
|
|
|
|
$0 |
|
|
VA/DoD Total Funds |
$500,000 |
$500,000 |
$500,000 |
$500,000 |
$5,050,000 |
$7,050,000 |
$3,000,000 |
|